Spinal nicotinic receptor expression in spontaneously hypertensive rats.

Intrathecal administration of nicotinic agonists previously has been shown to result in exaggerated pressor and heart rate responses as well as greater nociceptive behavior in adult (12-week-old) spontaneously hypertensive rats (SHR) than in age-matched normotensive Wistar-Kyoto rats (WKY). Paradoxical to these augmented responses to nicotinic agonists in SHR, nicotinic receptor number in the spinal cord as measured by cytisine binding sites is lower in adult SHR than normotensive WKY and Sprague-Dawley rats. Using the high-affinity agonist epibatidine, we found similar differences in receptor number between strains in both in vitro ligand binding experiments with spinal cord membranes and in situ autoradiographic analyses. Spinal nicotinic receptor number did not differ in 5-week-old prehypertensive SHR and age-matched WKY; however, receptor numbers were higher in young rats of both strains than in their adult counterparts. Antihypertensive treatment (25 mg/kg per day hydralazine PO) in 6-week-old SHR from 6 to 12 weeks of age markedly reduced the progressive rise in blood pressure yet did not alter nicotinic receptor number compared with untreated rats. Similar treatment of WKY with hydralazine produced a slight fall in blood pressure but no change in receptor number. Thus, normalization of blood pressure by hydralazine in SHR does not result in a return of receptor expression to levels seen in normotensive rats. Higher centrally mediated pressor activity or augmented postcoupling events after neuronal nicotinic receptor stimulation may slowly downregulate expression of spinal nicotinic receptors in this genetically hypertensive rat strain.

[1]  T. Yaksh,et al.  Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. , 1996, The Journal of pharmacology and experimental therapeutics.

[2]  J. Buccafusco The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. , 1996, Pharmacological reviews.

[3]  K. Kellar,et al.  Characterization of (+/-)(-)[3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. , 1995, Molecular pharmacology.

[4]  J. Elghozi,et al.  Effects of Bradykinin on Short‐Term Variability in Blood Pressure and Heart Rate in Rats: A Spectral Study , 1995, Journal of cardiovascular pharmacology.

[5]  B. Taylor,et al.  Peripheral beta adrenergic blockade modifies airpuff startle-induced heart rate responses. , 1995, The Journal of pharmacology and experimental therapeutics.

[6]  T. Yaksh,et al.  Stimulatory pathways and sites of action of intrathecally administered nicotinic agents. , 1994, The Journal of pharmacology and experimental therapeutics.

[7]  J. Buccafusco,et al.  Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioral function. , 1994, The Journal of pharmacology and experimental therapeutics.

[8]  T. Yaksh,et al.  Augmented responses to intrathecal nicotinic agonists in spontaneous hypertension. , 1994, Hypertension.

[9]  T. Yaksh,et al.  Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine. , 1994, The Journal of pharmacology and experimental therapeutics.

[10]  J. Daly,et al.  Epibatidine, a potent analgetic and nicotinic agonist. , 1994, Molecular pharmacology.

[11]  A. C. Collins,et al.  Downregulation of nicotinic receptor function after chronic nicotine infusion. , 1993, The Journal of pharmacology and experimental therapeutics.

[12]  D. Robertson,et al.  Effects of nicotine on brain stem mechanisms of cardiovascular control. , 1993, The Journal of pharmacology and experimental therapeutics.

[13]  R. Kline,et al.  Chronic hydralazine treatment alters the acute pressure-natriuresis curve in young spontaneously hypertensive rats. , 1991, Canadian journal of physiology and pharmacology.

[14]  M. Minami,et al.  The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats. , 1991, Clinical and experimental hypertension. Part A, Theory and practice.

[15]  J. Buccafusco,et al.  The pressor response to spinal cholinergic stimulation in spontaneously hypertensive rats , 1990, Brain Research Bulletin.

[16]  F. Wang,et al.  Differentiation of angiotensin-converting enzyme (ACE) inhibitors by their selective inhibition of ACE in physiologically important target organs. , 1989, American journal of hypertension.

[17]  H. Brezenoff,et al.  Suppression of hypertension during chronic reduction of brain acetylcholine in spontaneously hypertensive rats. , 1988, Journal of hypertension.

[18]  F. Leenen,et al.  Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. , 1988, Hypertension.

[19]  H. Brezenoff,et al.  Increased Central Cholinergic Activity in Rat Models of Hypertension , 1987, Journal of Cardiovascular Pharmacology.

[20]  S. Yamada,et al.  Brain nicotinic cholinoceptor binding in spontaneous hypertension , 1987, Brain Research.

[21]  R. Friedman,et al.  Participation of the Central Cholinergic System in Blood Pressure Regulation in the Dahl Rat Model of Essential Hypertension , 1983, Journal of Cardiovascular Pharmacology.

[22]  D. Jacobowitz,et al.  Changes in central cholinergic neurons in the spontaneously hypertensive rat , 1980, Brain Research.

[23]  W. Judy,et al.  Arterial Baroreceptor Reflex Control of Sympathetic Nerve Activity in the Spontaneously Hypertensive Rat , 1979, Hypertension.

[24]  W. Judy,et al.  Sympathetic Nerve Activity and Blood Pressure in Normotensive Backcross Rats Genetically Related to the Spontaneously Hypertensive Rat , 1979, Hypertension.

[25]  W. Hoffman,et al.  Central cholinergic and noradrenergic stimulation in spontaneously hypertensive rats. , 1978, Journal of Pharmacology and Experimental Therapeutics.